| The launch of new Rotavirus vaccines, the continuous market battle between Gardasil® and Cervarix™ in the HPV vaccine space, and the emerging field of therapeutic vaccines for autoimmune diseases, cancer and neurodegenerative diseases are all taking the industry by storm! Spurred by grants from non-profit agencies and promises from government bodies, the vaccine industry is experiencing unprecedented growth. Rapid advances in adjuvants, vectors and delivery technologies, and new developments in the use of cell substrates and disposable technologies are accelerating production and at the same time reducing manufacturing costs. To be a major player in the vaccine industry today you must know where the industry is heading, understand how your peers are doing, and most importantly, stay ahead of the curve. The Next Generation Vaccines event will feature TWO concurrent conferences: Discovery & Development and Production & Process Development. This will allow you the opportunity to network with attendees in either of these fields AND with those who are up- or down-stream from your own. This is your opportunity to learn what your peers are doing, understand where the latest technology innovations are coming from and learn how they are being channeled down. It is the one event that will give you TWO views - an overview of the industry from the discovery and development angle as well as the process development and production perspective. This highly acclaimed event will offer the depth of topics you need to further your insights into each area. | Discovery & Development | Production & Process Development | - Learn about the latest advances in adjuvants and immunogenicity of vaccines from Intercell, CSL, Dynavax, Emory University, NasVax, University of Nottingham and others
- Discover state-of-the-art delivery technologies from PowderMed, Inovio, OctoPlus, Emergent Biosolutions and more
- Gain first-hand insights into novel vaccines for cancer, autoimmune diseases, neurodegenerative diseases and infectious diseases from these industry leaders: Northwest BioTherapeutics; NHRI Taiwan, Bayhill Therapeutics, Oxford BioMedica, Merck & Co., National Institutes of Infectious Diseases Japan, Shanghai H&G Biotechnology, GENImmune and more
| - Special Session on "Development and Manufacturing of BioDefense Vaccines", featuring DARPA, BARDA, HPA, VaxDesign, Dynport etc.
- Gain tips on maintaining cost-efficiency in vaccine production with disposables and automation
- Expand your knowledge on the use of embryonic stem cells and cell substrates in vaccine production by Vivalis, Sanofi-Pasteur and others
- Learn how AERAS, IAVI and Merck have overcome the challenges of scale-up and pilot production for large scale cell culture and clinical trials
- Uncover the latest developments in biological assays from Merck, MedImmune and HPA UK etc.
| | | Keynote Presentations  | Regulation of Vaccines: Opportunities & Challenges
Norman Baylor, Ph.D., Director, Office of Vaccines Review and Research, CBER, FDA |  | New Vaccine Introduction in Developing Countries: Perspectives from the Americas
Jon Kim Andrus, M.D., Lead Technical Advisor, Immunization Unit, Pan American Health Organization/World Health Organization (PAHO/WHO) |  | Using Genomics to Develop Vaccines for Meningitis
Rino Rappuoli, Ph.D., Global Head, Vaccines Research, Novartis |  | Emergency Preparedness and Response- How Vaccines Can Play A Major Role
Steve Chatfield, Ph.D., Director, Centre for Emergency Preparedness and Response, Health Protection Agency, United Kingdom | | | Scientific Advisory Board Jean-Louis Excler, Ph.D., Senior Director, Medical Affairs, International AIDS Vaccine Initiative (IAVI) Arthur Krieg, M.D., Chief Scientific Officer & EVP R&D, Coley Pharmaceutical Group, Inc. A. Krishna Prasad, Ph.D., Associate Director, Vaccines Research, Wyeth Amit Vasavada, Ph.D., Director, Process Development Engineering, Vical Incorporated Genevieve Inchauspe, Ph.D., Head, Infectious Disease Department, R&D, Transgene France | | Interested in sending a group? Register 3 at the Standard Rate and the 4th Goes Free! When three members of the same company register and pay for the conference at the same time, the fourth attends for FREE! This discount is valid only based on the standard rate (rate after June 22, 2008). For more information on the group rates or to register your group, please call customer service at (800) 390-4078. | | |
